Evidence map›Paper›PMID 30834999›Full record

ReviewCurrent oncology reports2019

Novel Imaging in Detection of Metastatic Prostate Cancer.

Clayton P Smith, Anna Laucis, Stephanie Harmon, Esther Mena, Liza Lindenberg, Peter L Choyke, Baris Turkbey

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. [European journal of nuclear medicine and molecular imaging · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Metastatic Prostate Adenocarcinoma Presenting as Acute Quadriplegia: A Diagnostic Pitfall.Nigerian medical journal : journal of the Nigeria Medical Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Clayton P SmithMolecular Imaging Program, National Cancer Institute, NIH, Building 10 - Room B3B85, Bethesda, MD, 20892, USA.
Anna LaucisDepartment of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Stephanie HarmonMolecular Imaging Program, National Cancer Institute, NIH, Building 10 - Room B3B85, Bethesda, MD, 20892, USA.
Esther MenaMolecular Imaging Program, National Cancer Institute, NIH, Building 10 - Room B3B85, Bethesda, MD, 20892, USA.
Liza LindenbergMolecular Imaging Program, National Cancer Institute, NIH, Building 10 - Room B3B85, Bethesda, MD, 20892, USA.
Peter L ChoykeMolecular Imaging Program, National Cancer Institute, NIH, Building 10 - Room B3B85, Bethesda, MD, 20892, USA.
Baris TurkbeyMolecular Imaging Program, National Cancer Institute, NIH, Building 10 - Room B3B85, Bethesda, MD, 20892, USA. turkbeyi@mail.nih.gov.
National Cancer Institute · USUniversity of Michigan–Ann Arbor · US

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
6 · The paper itself

Abstract

purpose of reviewThis review aims to highlight the limitations of current standard-of-care prostate cancer (PCa) imaging and discuss novel clinical imaging in advanced disease. RECENT

findingsPCa staging through imaging is important for proper selections in clinical treatment. Traditional imaging techniques for metastatic disease (i.e., computed tomography [CT], magnetic resonance imaging [MRI], and radionuclide bone scan) have suboptimal performance in early recurrent or metastatic disease. Novel positron emission tomography agents including radiolabeled prostate specific membrane antigen (PSMA), choline, and anti-

Indexed as

HumansMagnetic Resonance ImagingMaleMultimodal ImagingNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyProstatic NeoplasmsRadiopharmaceuticalsRadiopharmaceuticalsCholineFluciclovineNovel prostate cancer imagingPET agentsProstate cancerPSMA

Identifiers

PMID30834999
OpenAlexW2920107756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.